Daniel Bexell

2.7k total citations · 1 hit paper
39 papers, 1.8k citations indexed

About

Daniel Bexell is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Daniel Bexell has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Neurology and 16 papers in Cancer Research. Recurrent topics in Daniel Bexell's work include Neuroblastoma Research and Treatments (19 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Virus-based gene therapy research (5 papers). Daniel Bexell is often cited by papers focused on Neuroblastoma Research and Treatments (19 papers), Cancer, Hypoxia, and Metabolism (15 papers) and Virus-based gene therapy research (5 papers). Daniel Bexell collaborates with scholars based in Sweden, Spain and Netherlands. Daniel Bexell's co-authors include Sven Påhlman, Caroline Wigerup, Johan Bengzon, Stefan Scheding, Salina Gunnarsson, David Gisselsson, Anna Darabi, Andreas Svensson, Noémie Braekeveldt and Sofie Mohlin and has published in prestigious journals such as Nature Communications, Nature Genetics and Cancer Research.

In The Last Decade

Daniel Bexell

37 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

2016 546 citations Caroline Wigerup, Sven Påhlman et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Bexell Sweden	21	848	742	539	351	307	39	1.8k
Alexander Pietras Sweden	20	1.1k 1.3×	1.2k 1.6×	581 1.1×	391 1.1×	287 0.9×	32	2.2k
Fumiharu Ohka Japan	23	1.0k 1.2×	678 0.9×	309 0.6×	525 1.5×	129 0.4×	99	1.8k
Márcia Regina Machein Germany	22	926 1.1×	632 0.9×	430 0.8×	494 1.4×	111 0.4×	28	1.6k
Elena I. Fomchenko United States	13	773 0.9×	388 0.5×	605 1.1×	582 1.7×	101 0.3×	23	1.5k
Helena Carén Sweden	26	1.4k 1.6×	767 1.0×	423 0.8×	537 1.5×	670 2.2×	76	2.1k
Arend Koch Germany	34	1.4k 1.7×	421 0.6×	415 0.8×	848 2.4×	333 1.1×	85	2.6k
Alessandra Pattarozzi Italy	31	1.0k 1.2×	329 0.4×	815 1.5×	396 1.1×	162 0.5×	51	2.1k
Akio Soeda Japan	15	560 0.7×	456 0.6×	564 1.0×	498 1.4×	474 1.5×	24	1.7k
Luca Persano Italy	26	1.1k 1.3×	676 0.9×	591 1.1×	572 1.6×	71 0.2×	55	2.0k
Annika Jögi Sweden	20	868 1.0×	934 1.3×	413 0.8×	120 0.3×	297 1.0×	30	1.6k

Countries citing papers authored by Daniel Bexell

Since Specialization

Citations

This map shows the geographic impact of Daniel Bexell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bexell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bexell more than expected).

Fields of papers citing papers by Daniel Bexell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bexell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bexell. The network helps show where Daniel Bexell may publish in the future.

Co-authorship network of co-authors of Daniel Bexell

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bexell. A scholar is included among the top collaborators of Daniel Bexell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bexell. Daniel Bexell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Jing, Miao Zhao, Xi Lu, et al.. (2025). Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma. Cell Death and Disease. 16(1). 554–554.

Bedoya-Reina, Oscar C., et al.. (2025). Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma. npj Precision Oncology. 9(1). 311–311.

Karlsson, Jenny, Karin Hansson, Kristina Aaltonen, et al.. (2024). Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma. Nature Communications. 15(1). 8992–8992. 4 indexed citations

Valind, Anders, Bronte Manouk Verhoeven, Jens Enoksson, et al.. (2023). Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy. OncoImmunology. 12(1). 2184130–2184130. 10 indexed citations

Källberg, Eva, Camilla Rydberg Millrud, Daniel Bexell, et al.. (2023). Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells. Frontiers in Immunology. 14. 1180209–1180209. 16 indexed citations

Aaltonen, Kristina, Karin Hansson, Hilda van den Bos, et al.. (2022). Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance. Science Advances. 8(43). eabq4617–eabq4617. 20 indexed citations

Ruiz-Pérez, María Victoria, Lourdes Sainero‐Alcolado, Ganna Oliynyk, et al.. (2021). Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. iScience. 24(2). 102128–102128. 30 indexed citations

Hansson, Karin, Kristina Aaltonen, Jani Saarela, et al.. (2020). Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science Translational Medicine. 12(562). 22 indexed citations

Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations

10.

Hagerling, Catharina, Caroline Bergenfelz, Eva Källberg, et al.. (2020). Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells. Experimental Cell Research. 390(1). 111932–111932. 8 indexed citations

11.

Elgendy, Ramy, Thale Kristin Olsen, Cecilia Dyberg, et al.. (2020). Integrative discovery of treatments for high-risk neuroblastoma. Nature Communications. 11(1). 71–71. 44 indexed citations

12.

Karlsson, Jenny, Anders Valind, Linda Holmquist Mengelbier, et al.. (2018). Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer. Nature Genetics. 50(7). 944–950. 46 indexed citations

13.

Persson, C., Kristoffer von Stedingk, Daniel Bexell, et al.. (2017). Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum. Scientific Reports. 7(1). 10274–10274. 24 indexed citations

14.

Wigerup, Caroline, Sven Påhlman, & Daniel Bexell. (2016). Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacology & Therapeutics. 164. 152–169. 546 indexed citations breakdown →

15.

Mohlin, Sofie, Kristoffer von Stedingk, Esther Bridges, et al.. (2015). PI3K–mTORC2 but not PI3K–mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma. Cancer Research. 75(21). 4617–4628. 76 indexed citations

16.

Svensson, Andreas, Sara Fritzell, Daniel Bexell, et al.. (2014). Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas. Journal of Neuroimmunology. 274(1-2). 240–243. 9 indexed citations

17.

Bexell, Daniel, Andreas Svensson, & Johan Bengzon. (2012). Stem cell-based therapy for malignant glioma. Cancer Treatment Reviews. 39(4). 358–365. 69 indexed citations

18.

Bexell, Daniel, Salina Gunnarsson, Andreas Svensson, et al.. (2011). Rat Multipotent Mesenchymal Stromal Cells Lack Long-Distance Tropism to 3 Different Rat Glioma Models. Neurosurgery. 70(3). 731–739. 25 indexed citations

19.

Bexell, Daniel, Salina Gunnarsson, Ariane Tormin, et al.. (2008). Bone Marrow Multipotent Mesenchymal Stroma Cells Act as Pericyte-like Migratory Vehicles in Experimental Gliomas. Molecular Therapy. 17(1). 183–190. 199 indexed citations

20.

Bexell, Daniel, et al.. (2007). Characterization of the subventricular zone neurogenic response to rat malignant brain tumors. Neuroscience. 147(3). 824–832. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact